Eric Mosbrooker
Chief Commercial Officer · Avidity Biosciences, Inc.
- 2025
- Feb 27, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Eric Mosbrooker files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sarah Boyce - $1.04M in RNAM purchases and sales in the last 12 months
- W. Michael Flanagan - $473K in RNAM purchases and sales in the last 12 months
- Steven George Hughes - $460K in RNAM purchases and sales in the last 12 months
- Michael F. Maclean - $329K in RNAM purchases and sales in the last 12 months
- Teresa McCarthy - $212K in RNAM purchases and sales in the last 12 months
- Arthur A. Levin - $127K in RNAM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Eric Mosbrooker?
Eric Mosbrooker is a corporate insider, tracked as Chief Commercial Officer of Avidity Biosciences, Inc. (RNAM). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Eric Mosbrooker last file a Form 4?
The most recent primary Form 4 on record is dated 27 February 2026, one of 4 filings going back to 2025.
Has Eric Mosbrooker been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($6.37M) across all tracked filings.
